Dynamics Group AG | WebDisclosure

Basculer en Français

9807	Companies
196719	Keywords
127725	Articles
104586	Press releases

Home
Companies
Dynamics Group AG

BRIEF

published on 02/05/2026 at 07:35, 2 hours 44 minutes ago

La Lituanie choisit Procivis comme environnement de test pour l'identité numérique.

Identité Numérique Lituanie Procivis EIDAS 2.0 Portefeuille EUDI
BRIEF

published on 02/05/2026 at 07:35, 2 hours 44 minutes ago

Lithuania Chooses Procivis for Digital Identity Sandbox

Digital Identity Lithuania Procivis EIDAS 2.0 EUDI Wallet
PRESS RELEASE

published on 02/05/2026 at 07:30, 2 hours 49 minutes ago

Lithuania Selects Procivis for the National European Digital Identity Wallet Sandbox
Lithuania selects Procivis to provide EUDI Wallet sandbox, facilitating digital identity activities and readiness for EU-wide launch. Procivis One technology ensures secure interoperability and regulatory alignment

Digital Identity Sandbox Lithuania Procivis EUDI Wallet
BRIEF

published on 01/02/2026 at 08:05, 1 month 3 days ago

Frédéric Prince to Lead Neovii Pharmaceuticals as New CEO

CEO Transition Leadership Change Neovii Pharmaceuticals Frédéric Prince Christian Loss
BRIEF

published on 01/02/2026 at 08:05, 1 month 3 days ago

Frédéric Prince nommé PDG de Neovii Pharmaceuticals

Transition Du PDG Changement De Leadership Neovii Pharmaceuticals Frédéric Prince Perte Chrétienne
PRESS RELEASE

published on 01/02/2026 at 08:00, 1 month 3 days ago

CEO transition at Neovii Pharmaceuticals: Frédéric Prince to succeed Christian Loss, effective January 1st, 2026
Frédéric Prince to succeed Christian Loss as CEO of Neovii Pharmaceuticals on January 1st, 2026. Dr. Loss retires after distinguished career. Dr. Prince brings extensive experience in research & development and commercial functions

CEO Transition Leadership Roles Neovii Pharmaceuticals Frédéric Prince Christian Loss
BRIEF

published on 12/24/2025 at 13:03, 1 month 11 days ago

DiNABIOS Welcomes FDA Modernization Act 3.0 Passage

Innovation Drug Development FDA Modernization DiNABIOS New Approach Methodologies
BRIEF

published on 12/24/2025 at 13:03, 1 month 11 days ago

DiNABIOS se félicite de l'adoption de la loi de modernisation de la FDA 3.0

Innovation Développement De Médicaments DiNABIOS Modernisation De La FDA Nouvelles Méthodologies D'approche
PRESS RELEASE

published on 12/24/2025 at 12:58, 1 month 11 days ago

DiNABIOS Applauds Historic U.S. Senate Passage of FDA Modernization Act 3.0, Advancing Human‑Relevant New Approach Methodologies (NAMs)
DiNABIOS celebrates U.S. Senate passage of FDA Modernization Act 3.0, promoting human-relevant NAMs for drug development and reducing animal testing

Drug Development DiNABIOS FDA Modernization Act 3.0 NAMs Animal Testing
BRIEF

published on 12/23/2025 at 14:41, 1 month 12 days ago

DiNAQOR présente une plateforme révolutionnaire pour l'administration de médicaments de précision.

Biotechnologie Thérapie Génique Médecine De Précision DiNAQOR Perfusion Loco-régionale

Accesswire

Published on 02/05/2026 at 09:05, 1 hour 14 minutes ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 8 hours 44 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 10 hours 19 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 11 hours 54 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 16 hours 19 minutes ago

Lithium South AGSM Update

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 10:05, 14 minutes ago

VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
Published on 02/05/2026 at 10:05, 14 minutes ago

Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese
Published on 02/05/2026 at 09:00, 1 hour 18 minutes ago

Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 1 hour 18 minutes ago

Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 1 hour 18 minutes ago

Original-Research: Semperit AG Holding (von NuWays AG): BUY

Les Echos

Published on 02/04/2026 at 18:04, 16 hours 15 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 16 hours 15 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 16 hours 34 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 16 hours 34 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 16 hours 34 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE